Basics ARS Pharmaceuticals, Inc. IPO Date: December 4, 2020 Sector: Healthcare Industry: Biotech Market Cap: $1.44B Activated in VL: True Average Daily Range Avg Daily Range: $0.27 | 2.91% Avg Daily Range (30 D): $0.31 | 2.23% Avg Daily Range (90 D): $0.40 | 3.13% Institutional Daily Volume Avg Daily Volume: .84M Avg Daily Volume (30 D): 1.21M Avg Daily Volume (90 D): 1.4M Trade Size Avg Trade Size (Sh.): 93 Avg Trade Size (Sh.) (30 D): 71 Avg Trade Size (Sh.) (90 D): 79 Institutional Trades Total Inst.Trades: 471 Avg Inst. Trade: $1.53M Avg Inst. Trade (30 D): $1.68M Avg Inst. Trade (90 D): $1.8M Avg Inst. Trade Volume: .14M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.63M Avg Closing Trade (30 D): $1.87M Avg Closing Trade (90 D): $1.91M Avg Closing Volume: 146.4K         News Jan 6, 2025 @ 1:00 PM ARS Pharmaceuticals Files for Approval of neffyÂÂ... Source: N/A Dec 13, 2024 @ 9:58 PM ARSファーマシューã... Source: N/A Dec 13, 2024 @ 9:58 PM ARS Pharmaceuticals 宣布在中å›Â... Source: Ars Pharmaceuticals, Inc. Dec 12, 2024 @ 7:32 PM ARS Pharmaceuticals Announces Filings for Approval... Source: Ars Pharmaceuticals, Inc. Nov 6, 2024 @ 3:00 PM The Physician-Patient Alliance for Health & Safety... Source: Globe Newswire Financials   TTM Q4 2024 FY 2024 Basic EPS $-.35 $.51 $.08 Diluted EPS $-.35 $.51 $.08 Revenue $ 7.97M $ 86.58M $ 89.15M Gross Profit $ $ $ Net Income / Loss $ -33.94M $ 49.93M $ 8M Operating Income / Loss $ -37.18M $ 47.2M $ -3.08M Cost of Revenue $ $ $ Net Cash Flow $ -10.95M $ 11.16M $ -20.15M PE Ratio